Evidence map›Paper›PMID 21838300›Full record

ArticleACS nano2011

Endothelial targeting of antibody-decorated polymeric filomicelles.

Vladimir V Shuvaev, Marc A Ilies, Eric Simone, Sergei Zaitsev, Younghoon Kim, Shenshen Cai, Abdullah Mahmud, Thomas Dziubla, Silvia Muro, Dennis E Discher and 1 more

Abstract read
In one paragraph

Article in ACS nano, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Pharmacokinetic and Pharmacodynamic Properties of Drug Delivery Systems.The Journal of pharmacology and experimental therapeutics · 2019
    Review
  13. Review
  14. Review
  15. The Future of Nanoparticle-Directed Venous Therapy.Seminars in interventional radiology · 2017
    Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Vladimir V ShuvaevInstitute for Translational Medicine & Therapeutics and Department of Pharmacology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104-5158, USA.
Marc A Ilies
Eric Simone
Sergei Zaitsev
Younghoon Kim
Shenshen Cai
Abdullah Mahmud
Thomas Dziubla
Silvia Muro
Dennis E Discher
Vladimir R Muzykantov

Funding

Reactive oxygen species and anti-oxidants in ALIP01HL079063 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI BATES, SANDRA R · 2005 to 2009
$12.1M
Targeted replacement of defective lysosomal enzymes in the lung and brainR01HL098416 · NHLBI · UNIV OF MARYLAND, COLLEGE PARK · PI MURO, SILVIA · 2010 to 2020
$3.3M
Carrier Shape Matters: Filomicelles, Long-circulation, and the EPR effectR01EB007049 · NIBIB · UNIVERSITY OF PENNSYLVANIA · PI DISCHER, DENNIS E. · 2006 to 2014
$2.8M
Targeting Carriers with Controlled Geometry to EndotheliumR01HL087036 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI MUZYKANTOV, VLADIMIR R · 2008 to 2012
$2.0M
Augmentation of Antioxidant Defenses by ImmunotargetingR01HL073940 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI MUZYKANTOV, VLADIMIR R · 2004 to 2007
$1.6M
NHLBI NIH HHS HL087036NHLBI NIH HHS P01 HL079063NHLBI NIH HHS R01 HL073940NHLBI NIH HHS R01 HL087036NHLBI NIH HHS R01 HL098416NIBIB NIH HHS R01 EB007049
6 · The paper itself

Abstract

The endothelial lining of the lumen of blood vessels is a key therapeutic target for many human diseases. Polymeric filomicelles that self-assemble from polyethylene oxide (PEO)-based diblock copolymers are long and flexible rather than small or rigid, can be loaded with drugs, and--most importantly--they circulate for a prolonged period of time in the bloodstream due in part to flow alignment. Filomicelles seem promising for targeted drug delivery to endothelial cells because they can in principle adhere strongly, length-wise to specific cell surface determinants. In order to achieve such a goal of vascular drug delivery, two fundamental questions needed to be addressed: (i) whether these supramolecular filomicelles retain structural integrity and dynamic flexibility after attachment of targeting molecules such as antibodies, and (ii) whether the avidity of antibody-carrying filomicelles is sufficient to anchor the carrier to the endothelial surface despite the effects of flow that oppose adhesive interactions. Here we make targeted filomicelles that bear antibodies which recognize distinct endothelial surface molecules. We characterize these antibody targeted filomicelles and prove that (i) they retain structural integrity and dynamic flexibility and (ii) they adhere to endothelium with high specificity both in vitro and in vivo. These results provide the basis for a new drug delivery approach employing antibody-targeted filomicelles that circulate for a prolonged time yet bind to endothelial cells in vascular beds expressing select markers.

Indexed as

Drug Delivery SystemsMicellesPolymersAntibodiesEndothelium, VascularHumansNanoparticlesAntibodiesMicellesPolymers

Identifiers

PMID21838300
PMCPMC3342815

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.